Combination Therapy of AK112 With Chemotherapy and/or Olaparib in Platinum-sensitive Ovarian Cancer

Clinical trial NCT06686030 · RECRUITING

Trial details

NCT number: NCT06686030
Sponsor: Akeso
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Platinum-sensitive Ovarian Cancer

Start date: 2025-02-17
Primary completion: 2027-10-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.